Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease

Published:2005-09 Issue:6 Volume:93 Page:633-638
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Berruti A,Tucci M,Mosca A,Tarabuzzi R,Gorzegno G,Terrone C,Vana F,Lamanna G,Tampellini M,Porpiglia F,Angeli A,Scarpa R M,Dogliotti L

Publisher

Springer Science and Business Media LLC

Link

http://www.nature.com/articles/6602767.pdf

Reference20 articles.

1. Bayley A, Milosevic M, Blend R, Logue J, Gospodarowicz M, Boxen I, Warde P, McLean M, Catton C, Catton P (2001) A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer 92: 303–310

2. Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M, Torta M, Porpiglia F, Fontana D, Angeli A (2000) Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol 164 (4): 1248–1253

3. Berruti A, Dogliotti L, Tucci M, Tarabuzzi R, Guercio S, Torta M, Tampellini M, Dovio A, Poggio M, Scarpa RM, Angeli A (2002) Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. Int J Biol Markers 17 (4): 244–252

4. Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE (2005) Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97 (1): 59–69

5. Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163 (1): 181–186

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Lutetium‐177 PSMA Radioligand Therapy in Metastatic Castration‐Resistant Prostate Cancer with Diffuse Bone Metastases (Asian Population Study);Asia-Pacific Journal of Clinical Oncology;2025-05-29

2. Risk factors and clinical significance of refractory pain in patients with bone metastases: a comprehensive meta-analysis;Frontiers in Neurology;2025-04-24

3. Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma;European Journal of Cancer;2024-09

4. Role of osteoclast inhibitors in prostate cancer bone metastasis; a narrative review;Journal of Oncology Pharmacy Practice;2024-08-22

5. Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications;Cancers;2023-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3